Last reviewed · How we verify
DESF — Competitive Intelligence Brief
marketed
Potassium channel subfamily K member 10, Potassium channel subfamily K member 18, Potassium channel subfamily K member 2
Other
Small molecule
Live · refreshed every 30 min
Target snapshot
DESF (DESF) — Baxter Hlthcare. Desf works by interacting with a specific biological target to produce a therapeutic effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| DESF TARGET | DESF | Baxter Hlthcare | marketed | Potassium channel subfamily K member 10, Potassium channel subfamily K member 18, Potassium channel subfamily K member 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
Cite this brief
Drug Landscape (2026). DESF — Competitive Intelligence Brief. https://druglandscape.com/ci/desf. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab